Should I buy or sell Forian stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forian in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FORA shares. View FORA analyst ratings or view top-rated stocks .

What is Forian's stock price target for 2024?

4 brokers have issued 1-year price targets for Forian's stock. Their FORA share price targets range from $5.00 to $13.00. On average, they expect the company's stock price to reach $7.67 in the next year. This suggests a possible upside of 189.3% from the stock's current price. View analysts price targets for FORA or view top-rated stocks among Wall Street analysts .

How have FORA shares performed in 2024?

Forian's stock was trading at $2.93 at the start of the year. Since then, FORA stock has decreased by 9.6% and is now trading at $2.65. View the best growth stocks for 2024 here .

When is Forian's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our FORA earnings forecast .

What guidance has Forian issued on next quarter's earnings?

Forian issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $21.5 million-$23.6 million, compared to the consensus revenue estimate of $24.0 million.

How do I buy shares of Forian?

Shares of FORA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:FORA

Forian (FORA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free FORA Stock Alerts

$2.65

+0.13 (+5.16%)

(As of 04/19/2024 ET)

Compare

Today's Range: $2.47
▼
$2.74
50-Day Range: $2.46
▼
$3.64
52-Week Range: $1.85
▼
$4.15

Volume: 31,059 shs
Average Volume: 27,028 shs
Market Capitalization: $82.50 million

P/E Ratio: 8.03
Dividend Yield: N/A
Price Target: $7.67

Get Forian alerts:

Forian MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 189.3% Upside
$7.67 Price Target
Short Interest: Bearish
1.14% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.07
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.87 out of 5 stars

Medical Sector

600th out of 911 stocks

Health Information Services Industry

1st out of 2 stocks

3.5

Analyst's Opinion

Consensus Rating
Forian has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Forian has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.14% of the float of Forian has been sold short.
Short Interest Ratio / Days to Cover
Forian has a short interest ratio ("days to cover") of 6.5.
Change versus previous month
Short interest in Forian has recently increased by 0.36%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Forian does not currently pay a dividend.
Dividend Growth
Forian does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FORA.

1.1

News and Social Media Coverage

News Sentiment
Forian has a news sentiment score of -0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Forian this week, compared to 3 articles on an average week.
Search Interest
Only 2 people have searched for FORA on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Forian insiders have not sold or bought any company stock.
Percentage Held by Insiders
31.30% of the stock of Forian is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 19.25% of the stock of Forian is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Forian is 8.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.45.
Price to Earnings Ratio vs. Sector
The P/E ratio of Forian is 8.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 215.55.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Forian Stock (NASDAQ:FORA)

Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.

FORA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FORA Stock News Headlines

April 18, 2024 | msn.com

2025 Maserati GranCabrio Folgore EV Droptop Forecasts Sunny Days Ahead

April 15, 2024 | markets.businessinsider.com

Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

April 14, 2024 | globenewswire.com

Forian Inc. Announces the Passing of Director Martin J. Wygod

April 12, 2024 | businesswire.com

VerticalScope to Announce First Quarter 2024 Results

April 4, 2024 | msn.com

21 of the best medical dramas and TV series to watch if you like Grey’s Anatomy

April 2, 2024 | msn.com

A look at the 1,000 point scorers around Coshocton, Guernsey, Muskingum, Perry and Morgan counties

April 1, 2024 | msn.com

About the Browns & contract extensions; Nick Chubb; Cade York & more – Terry Pluto

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 1, 2024 | finance.yahoo.com

Forian Inc. (NASDAQ:FORA) Q4 2023 Earnings Call Transcript

March 31, 2024 | finance.yahoo.com

Forian Full Year 2023 Earnings: EPS Beats Expectations

March 31, 2024 | msn.com

March 29, 2024 | usatoday.com

Mikal Bridges: 'My other dream was being a second-grade teacher'

March 28, 2024 | benzinga.com

Recap: Forian Q4 Earnings

March 28, 2024 | finance.yahoo.com

Forian Inc (FORA) Outperforms Analyst Revenue Estimates and Achieves Positive Adjusted EBITDA

March 28, 2024 | globenewswire.com

Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

March 27, 2024 | benzinga.com

Earnings Outlook For Forian

March 23, 2024 | theguardian.com

‘End of the world vibes’: why culture can’t stop thinking about apocalypse

March 17, 2024 | msn.com

Will the Browns pursue WR Mike Williams now that the Chargers have cut him? Hey, Mary Kay!

March 15, 2024 | msn.com

Browns 53-man roster after the first wave of NFL free agency

March 14, 2024 | msn.com

TKO Closes Its Stall in East Atlanta’s Southern Feedstore

March 14, 2024 | msn.com

Check out who made all-league in the KMAC and CBC during winter sports this season

March 13, 2024 | msn.com

NFL free agency 2024: Browns bring in ex-Panthers tight end Giovanni Ricci

March 13, 2024 | businesswire.com

VerticalScope Announces Fourth Quarter and Full Year 2023 Financial Results

March 13, 2024 | bbc.co.uk

Francis Ford Coppola on why The Godfather was really about the US

March 11, 2024 | investorplace.com

7 Growth Stocks That Could Turn $10,000 Into $500,000

March 11, 2024 | msn.com

Virginia Rides Offense to Avoid Sweep, Takes Game 3 at Miami 14-11

See More Headlines

Receive FORA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forian and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/10/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: NASDAQ:FORA
CUSIP: N/A
CIK: 1829280
Web: forian.com
Phone: +17203285372
Fax: N/A
Employees: 102
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.67
High Stock Price Target: $13.00
Low Stock Price Target: $5.00
Potential Upside/Downside: +189.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 8.03
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $20.48 million
Price / Sales: 4.03
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 31,132,000
Free Float: N/A
Market Cap: $82.50 million
Optionable: Optionable
Beta: 1.03

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Michael Vesey (Age 62)
Chief Financial Officer
Comp: $457k
Mr. Edward Francis Spaniel Jr. (Age 54)
Executive VP, General Counsel & Secretary
Comp: $395.8k
Mr. Max C. Wygod (Age 36)
Co-Founder, CEO, President & Executive Chairman of the Board
Comp: $46.88k
Mr. Adam H. Dublin (Age 58)
Co-Founder, Chief Strategy Officer & Director
Comp: $113.7k
Mr. Jason Holden
Vice President of Corporate Development
Rebecca Adams
Vice President of Human Resources
Paul Reuscher
Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

FORA Stock Analysis - Frequently Asked Questions

Should I buy or sell Forian stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forian in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FORA shares.
View FORA analyst ratings or view top-rated stocks.
What is Forian's stock price target for 2024?: 4 brokers have issued 1-year price targets for Forian's stock. Their FORA share price targets range from $5.00 to $13.00. On average, they expect the company's stock price to reach $7.67 in the next year. This suggests a possible upside of 189.3% from the stock's current price.
View analysts price targets for FORA or view top-rated stocks among Wall Street analysts.
How have FORA shares performed in 2024?: Forian's stock was trading at $2.93 at the start of the year. Since then, FORA stock has decreased by 9.6% and is now trading at $2.65.
View the best growth stocks for 2024 here.
When is Forian's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our FORA earnings forecast.

What guidance has Forian issued on next quarter's earnings?: Forian issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $21.5 million-$23.6 million, compared to the consensus revenue estimate of $24.0 million.
How do I buy shares of Forian?: Shares of FORA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FORA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial